ALEX OSHMYANSKY Trademark

Trademark Overview

On Friday, March 11, 2022, a trademark application was filed for ALEX OSHMYANSKY with the United States Patent and Trademark Office. The USPTO has given the ALEX OSHMYANSKY trademark a serial number of 97307516. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, July 31, 2024. This trademark is owned by Mark Cuban Cost Plus Drug Company, PBC. The ALEX OSHMYANSKY trademark is filed in the Treatment & Processing of Materials Services category with the following description:

Custom manufacture of a full line of drugs, medications, and pharmaceuticals by pharmaceutical compounders
alex oshmyansky

General Information

Serial Number97307516
Word MarkALEX OSHMYANSKY
Filing DateFriday, March 11, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateWednesday, July 31, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 20, 2023

Trademark Statements

Goods and ServicesCustom manufacture of a full line of drugs, medications, and pharmaceuticals by pharmaceutical compounders

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateWednesday, March 16, 2022
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMark Cuban Cost Plus Drug Company, PBC
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLittleton, CO 80123
Party NameMark Cuban Cost Plus Drug Company, PBC
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLittleton, CO 80123

Trademark Events

Event DateEvent Description
Tuesday, March 15, 2022NEW APPLICATION ENTERED
Wednesday, March 16, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 22, 2022ASSIGNED TO EXAMINER
Thursday, December 22, 2022NON-FINAL ACTION WRITTEN
Thursday, December 22, 2022NON-FINAL ACTION E-MAILED
Thursday, December 22, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 10, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 10, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 10, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 11, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, May 11, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, May 11, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, May 11, 2023EXAMINER'S AMENDMENT ENTERED
Thursday, May 11, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 31, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 20, 2023PUBLISHED FOR OPPOSITION
Tuesday, June 20, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 15, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 23, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, July 31, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, July 31, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 31, 2024SOU EXTENSION 2 FILED
Wednesday, July 31, 2024SOU EXTENSION 2 GRANTED
Tuesday, January 23, 2024SOU EXTENSION 1 FILED
Tuesday, January 23, 2024SOU EXTENSION 1 GRANTED
Thursday, January 25, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

oshmyansky alex pharmaceuticals pharmaceutical compounders medications drugs manufacture full line custom